YDYiyi Ding

Yiyi Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yiyi Ding has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Hongyan Tang

    The First People's Hospital of Changde City, Changde, Hunan, China

    2 shared publications
  • Rong Hu

    The First People's Hospital of Changde City, Changde, Hunan, China

    2 shared publications
  • Chao Liu

    Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

    1 shared publication
  • Chaojun Zhou

    Department of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People’s Hospital of Changde City), Changde, Hunan, China

    1 shared publication
  • Guilan Tang

    Department Clinical Laboratory, The First People’s Hospital of Changde City, Changde, China

    1 shared publication
  • H J Hua

    Departmen of Pathology, Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University), Nanjing 210029, China

    1 shared publication

Latest Publications

  • Open Access

    Fatal Acute Necrotizing Encephalopathy in a 17-Year-Old Girl with COVID-19: A Case Report

    by Jianming Zhu, Yanling Li, Jianyi Liu, Chaojun Zhou, Xianglin Liu, Yiyi Ding

    BACKGROUND Acute necrotizing encephalopathy (ANE) is a severe and rapidly progressive form of encephalopathy predominantly observed in children following various systemic infections. Although rare, cases of ANE have been increasingly associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This report details a fatal case of ANE in a 17-year-old girl diagnosed with coronavirus disease 2019 (COVID-19), emphasizing the critical need for early diagnosis and prompt intervention to improve clinical outcomes. CASE REPORT A previously healthy 17-year-old girl presented with a 3-day history of fever followed by onset of seizures and consciousness disorders after testing positive for SARS-CoV-2. Cranial magnetic resonance imaging (MRI) revealed bilateral symmetrical thalamus, which is a typical imaging presentation of ANE. Cerebrospinal fluid (CSF) examination revealed a normal cell count. Differential diagnoses such as acute disseminated encephalomyelitis (ADEM) and Leigh syndrome were excluded, leading to a diagnosis of ANE. Despite aggressive treatment, including respiratory support, intravenous immunoglobulin, and high-dose glucocorticoids, the patient's condition deteriorated rapidly, resulting in death the following day. CONCLUSIONS ANE is a rare but devastating condition in adolescents, particularly following viral infections such as COVID-19. It should be considered in patients presenting with seizures and progressive consciousness disorders after viral infection. Urgent neuroimaging and lumbar puncture are essential for diagnosis. Early recognition, immunotherapy, and aggressive management are crucial to mitigate the high mortality associated with this severe neurological disorder.


  • Open Access

    Association between phosphate and 30-day in-hospital mortality in paediatric ICU: a retrospective cohort study

    by Yiyi Ding, Yaqin Lei, Yufang Zhu, Hongwei Zhang, Yunbin Xiao

    Background: Death rates in the intensive care unit (ICU) and paediatric ICU (PICU) are approximately 10.8% and 9.13%, respectively. Serum phosphate irregularities, such as low or high phosphate levels, significantly impact ICU patient outcomes. However, the connection between serum phosphate concentrations on admission and PICU mortality has not been investigated.Methods: Information was collected from 12 881 PICU patients at the Children’s Hospital, Zhejiang University School of Medicine, over an 8-year period from 2010 to 2018. The data were retrieved from the PIC database (http://pic.nbscn.org).Results: A multiple linear regression model was used to assess associations between phosphate and 30-day PICU mortality, finding a significant positive relationship (OR 1.27, 95% CI 1.08 to 1.49). Generalised additive models were also developed, showing a non-linear association between serum phosphate and 30-day PICU mortality. In the two-phase linear regression analysis, the critical point for serum phosphate concentration was identified as 1.2 mmol/L. To the left of this point, serum phosphate levels were inversely correlated (OR 0.2, 95% CI 0.10 to 0.41), whereas to the right, a positive relationship was observed (OR 1.99, 95% CI 1.66 to 2.39).Conclusions: The findings demonstrated a relationship between serum phosphate levels and 30-day PICU mortality. The relationship was represented by a U-shaped curve. Hypophosphataemia and hyperphosphataemia increased the risk of 30-day PICU death.


  • Open Access

    Evaluation of Risk Factors for Children with Severe Adenovirus Respiratory Infection: Retrospective Study

    by Xian Liu, Yiyi Ding, Rong Hu, Hongyan Tang

    Background: Human adenovirus (HAdV) commonly affects children hospitalized with any form of respiratory infection (RI). Severe HAdV infection leads to one of the most serious types of infantile RI, with rapidly progressive illness and a poor prognosis. Objectives: This study investigated the relationship between aspartate aminotransferase (AST) levels and the severity of HAdV RI in children. Methods: We collected clinical data from 665 cases of HAdV RI in children hospitalized at the pediatric ward of Changde First People's Hospital between January and December 2019. We analyzed the relationship between AST levels and disease severity. Results: Of the 665 HAdV-positive cases, 89.8% were < 6 years of age. Among them, upper RI was diagnosed in 18.8% of cases, bronchiolitis in 4.8%, and mild pneumonia in 48.1%. Severe pneumonia was observed in 28.2% of cases. The 665 patients in the cohort were divided into a mild group (n = 477 cases, 71.73%) and a severe group (n = 188 cases, 28.27%). Univariate analysis showed that children with severe HAdV RI had a lower age of onset and lower hemoglobin and serum albumin levels while having higher platelet counts, lactic acid dehydrogenase, creatine kinase, creatine kinase isoenzyme, alanine aminotransferase, and AST levels compared to those with mild infections (P < 0.05). Multivariate analysis revealed that these factors were related to disease severity (P < 0.05). The ROC curve analysis indicated that the area under the AST curve was 0.782. When the intercept value was 52.5 U/L, the sensitivity was 60.6%, and the specificity was 83.4%. Conclusions: Serum AST levels can serve as a predictor of adenoviral RI severity in children.


  • Open Access

    Monocyte count is associated with the severity of human adenovirus pneumonia in hospitalized children aged less than 6 years

    by Rong Hu, Xiaorong Luo, Guilan Tang, Yiyi Ding

    Background: Human Adenovirus (HAdV) pneumonia is common in young children and infants. Overall, 7–8% of all viral respiratory illnesses among children for less than 5 years are induced by HAdVs. Unfortunately little is known about the role of monocyte count in the disease severity. Methods: Data were gathered from 595 children (age < 6 years) who were diagnosed with HAdV infection at the 1st People's Hospital (Changde City, China) between January 2019 and December 2019. There were 181 cases of severe adenovirus pneumonia. Results: The correlation between the patients' monocyte count and the severity of HAdV pneumonia was estimated by performing a multiple linear regression analysis. The results showed a negative association (OR: 0.53, 95% CI 0.31 to 0.89, P < 0.05). We further built Generalized Additive Models (GAMs) and demonstrated that the monocyte count had a non-linear association with severe HAdV pneumonia. The inflection point of monocyte count detected in the two-stage linear regression model was 1.5. On the left side of this point, the monocyte count was negatively interrelated (OR: 0.26, 95% CI 0.13 to 0.52, P < 0.001), while on the opposite side, there was a positive association (OR: 7.48, 95% CI 1.30 to 43.08, P < 0.05). Conclusions: Based on the results of this investigation, we established a link between monocyte count and the severity of HAdV pneumonia. Monocyte count is negatively associated with severe HAdV pneumonia. The inflection point of monocyte count detected in the two-stage linear regression model was 1.5 × 109/L.


  • Open Access

    Massive gastrointestinal hemorrhage caused by Henoch-Schoenlein purpura

    by Shuo Wang, Hongyan Tang, Wei Du, Yiyi Ding

    Rationale: Henoch-Schoenlein purpura (HSP) is a systemic small-vessel vasculitis that commonly occurs in children. Gastrointestinal HSP can rarely progress to gastrointestinal perforation, followed by massive gastrointestinal bleeding. Patient concerns: An 8-year-old Chinese boy was transferred to the pediatric intensive care unit of our hospital with an emergency occurrence of purpura, severe hematemesis, large bloody stools, and sharp abdominal pain, and complained of abdominal pain and rash 2 weeks prior. Diagnosis: The patient had purpura with lower limb predominance, abdominal pain, and gastrointestinal bleeding. Immunofluorescence microscopy of histological sections showed granular and lumpy IgA focal deposition in the blood vessel walls. He was diagnosed with HSP. Interventions: Initially, he was treated with methylprednisolone, posterior pituitary injection, somatostatin, and hemocoagulase, together with the infusion of large blood products. Postoperatively, he was administered nasal continuous positive airway pressure -assisted ventilation, anti-infection treatment, albumin transfusion, platelet transfusion, abdominal drainage, methylprednisolone, fluconazole anti-fungal treatment, and wound dressing. Outcomes: There was no evidence of rebleeding, abdominal pain, or purpura at the 2-month follow-up assessment. Lessons: Abdominal HSP should be alert to gastrointestinal perforation when using hormone therapy.